Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Reyataz
| Field | Information |
|---|---|
| Medication Name | Reyataz |
| Generic Name | Atazanavir |
| Boxed/Label Warning | May cause serious liver problems. |
| Purpose | Antiretroviral medication used to treat HIV-1 infection |
| Mechanism of Action | Inhibits HIV-1 protease, preventing viral replication |
| Dosage Forms | Oral capsules |
| Available Strengths | 200 mg, 300 mg |
| Dosage Frequency | Once daily |
| Common Side Effects | Nausea, vomiting, diarrhea, abdominal pain, headache, jaundice |
| Serious Side Effects | Severe skin reactions, liver problems, heart rhythm changes, kidney stones, new or worsening diabetes |
| Drug Interactions | Many medications interact with atazanavir, including proton pump inhibitors (PPIs), statins, and some antibiotics. Consult a healthcare provider or pharmacist. |
| Important Notes | Take with food to enhance absorption. Monitor liver function regularly. May cause changes in heart rhythm. |
| Storage | Store at room temperature away from moisture and light |
| Missed Dose | Take as soon as you remember unless it is close to your next dose. Do not double the dose. |
| Alternatives | Darunavir (Prezista), Dolutegravir (Tivicay), Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Genvoya) |
Reyataz Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Darunavir (Prezista) | HIV-1 protease inhibitor | Often used in combination with ritonavir or cobicistat. |
| Dolutegravir (Tivicay) | Integrase strand transfer inhibitor (INSTI) | Highly effective and generally well-tolerated. |
| Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Genvoya) | INSTI-based single-tablet regimen | Convenient once-daily treatment option. |
Reyataz Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Nausea | Severe skin reactions (Stevens-Johnson syndrome) |
| Vomiting | Liver problems (hepatitis, jaundice) |
| Diarrhea | Heart rhythm changes (QT prolongation) |
| Abdominal pain | Kidney stones |
| Headache | New or worsening diabetes |
| Jaundice | Increased bilirubin levels (may cause yellowing of the skin or eyes) |
Reyataz Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| HIV-1 Infection (treatment-naive) | 300 mg | 300 mg once daily with ritonavir 100 mg or 400mg once daily without ritonavir. | Take with food to increase absorption. |
| HIV-1 Infection (experienced) | 300 mg | 300 mg once daily with ritonavir 100 mg. | May require adjustments based on viral load and resistance testing. |
